Cover Image
Market Research Report
Product code 
1034589

Spine Biologics Market Research Report by Product, by End-user, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

Published: | 360iResearch LLP | 192 Pages | Delivery time: 1-2 business days

Price

Back to Top
Spine Biologics Market Research Report by Product, by End-user, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
Published: October 28, 2021
360iResearch LLP
Content info: 192 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The Global Spine Biologics Market size was estimated at USD 3,198.53 million in 2020 and expected to reach USD 3,728.53 million in 2021, at a CAGR 16.90% to reach USD 8,166.32 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Spine Biologics to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Product, the market was studied across Bone Graft Substitutes, Cell-base Matrix, and Spinal Allografts. The Bone Graft Substitutes is further studied across Bone Morphogenetic Proteins and Synthetic Bone Grafts. The Spinal Allografts is further studied across Demineralized Bone Matrix and Machined Bones Allograft.
  • Based on End-user, the market was studied across Ambulatory Surgical Centers and Hospitals.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Spine Biologics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Spine Biologics Market, including Alphatec Spine, Inc, Arthrex, Inc., Axial Medical, Bacterin International, Inc., Cesca Therapeutics Inc.', ChoiceSpine LP, CTL Medical Corporation, DMP Spine, DR PRP USA LLC, Globus Medical, Inc., Innovasis, Jayon Implants, Johnson & Johnson Services Inc, Lattice Biologics Ltd., Life Spine, Inc., Medtronic PLC, NuVasive, Inc., Organogenesis, Inc., Orthofix Holdings, Inc, Precision Spine, RTI Surgical, SeaSpine Holdings, Smith & Nephew PLC, Stryker Corporation, and Zimmer Biomet.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Spine Biologics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Spine Biologics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Spine Biologics Market?
  • 4. What is the competitive strategic window for opportunities in the Global Spine Biologics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Spine Biologics Market?
  • 6. What is the market share of the leading vendors in the Global Spine Biologics Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Spine Biologics Market?
Product Code: MRR-A86604082636

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Define: Research Objective
  • 2.3. Determine: Research Design
  • 2.4. Prepare: Research Instrument
  • 2.5. Collect: Data Source
  • 2.6. Analyze: Data Interpretation
  • 2.7. Formulate: Data Verification
  • 2.8. Publish: Research Report
  • 2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand and preference for minimally invasive procedures
      • 5.1.1.2. Rising incidence of degenerative spine disorders and rise in treatment rates
      • 5.1.1.3. Proliferation in advancements of bone grafting procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Extremely high cost of these procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in biomaterials improving the treatment of spine diseases such as disc degeneration and scoliosis
      • 5.1.3.2. Government funding coupled with increased awareness attributed to reduced hospital stay
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternate substitute products in the market
  • 5.2. Cumulative Impact of COVID-19

6. Spine Biologics Market, by Product

  • 6.1. Introduction
  • 6.2. Bone Graft Substitutes
    • 6.2.1. Bone Morphogenetic Proteins
    • 6.2.2. Synthetic Bone Grafts
  • 6.3. Cell-base Matrix
  • 6.4. Spinal Allografts
    • 6.4.1. Demineralized Bone Matrix
    • 6.4.2. Machined Bones Allograft

7. Spine Biologics Market, by End-user

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals

8. Americas Spine Biologics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Spine Biologics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand

10. Europe, Middle East & Africa Spine Biologics Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Key Player
  • 11.4. Competitive Scenario
    • 11.4.1. Merger & Acquisition
    • 11.4.2. Agreement, Collaboration, & Partnership
    • 11.4.3. New Product Launch & Enhancement
    • 11.4.4. Investment & Funding
    • 11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Alphatec Spine, Inc
  • 12.2. Arthrex, Inc.
  • 12.3. Axial Medical
  • 12.4. Bacterin International, Inc.
  • 12.5. Cesca Therapeutics Inc.'
  • 12.6. ChoiceSpine LP
  • 12.7. CTL Medical Corporation
  • 12.8. DMP Spine
  • 12.9. DR PRP USA LLC
  • 12.10. Globus Medical, Inc.
  • 12.11. Innovasis
  • 12.12. Jayon Implants
  • 12.13. Johnson & Johnson Services Inc
  • 12.14. Lattice Biologics Ltd.
  • 12.15. Life Spine, Inc.
  • 12.16. Medtronic PLC
  • 12.17. NuVasive, Inc.
  • 12.18. Organogenesis, Inc.
  • 12.19. Orthofix Holdings, Inc
  • 12.20. Precision Spine
  • 12.21. RTI Surgical
  • 12.22. SeaSpine Holdings
  • 12.23. Smith & Nephew PLC
  • 12.24. Stryker Corporation
  • 12.25. Zimmer Biomet

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL SPINE BIOLOGICS MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL SPINE BIOLOGICS MARKET: MARKET DYNAMICS
  • FIGURE 3. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 4. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
  • FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 6. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2026 (USD MILLION)
  • FIGURE 7. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 8. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2018-2026 (USD MILLION)
  • FIGURE 9. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY CELL-BASE MATRIX, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY CELL-BASE MATRIX, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY MACHINED BONES ALLOGRAFT, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY MACHINED BONES ALLOGRAFT, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
  • FIGURE 21. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2026
  • FIGURE 23. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. AMERICAS SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 28. ARGENTINA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 29. BRAZIL SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 30. CANADA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 31. MEXICO SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 32. UNITED STATES SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 33. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 34. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 35. CHINA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 36. INDIA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 37. INDONESIA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 38. JAPAN SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 39. MALAYSIA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 40. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 41. SINGAPORE SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 42. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 43. TAIWAN SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 44. THAILAND SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 45. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 46. FRANCE SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 47. GERMANY SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 48. ITALY SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 49. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 50. QATAR SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 51. RUSSIA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 52. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 53. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 54. SPAIN SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 55. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 56. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 57. GLOBAL SPINE BIOLOGICS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 58. GLOBAL SPINE BIOLOGICS MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 59. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SPINE BIOLOGICS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL SPINE BIOLOGICS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
  • TABLE 4. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 5. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 6. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 7. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY CELL-BASE MATRIX, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 8. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 9. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 10. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY MACHINED BONES ALLOGRAFT, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 11. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD MILLION)
  • TABLE 12. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 13. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 14. AMERICAS SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 15. ARGENTINA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 16. BRAZIL SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 17. CANADA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 18. MEXICO SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 19. UNITED STATES SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 20. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 21. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 22. CHINA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 23. INDIA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 24. INDONESIA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 25. JAPAN SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 26. MALAYSIA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 27. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 28. SINGAPORE SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 29. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 30. TAIWAN SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 31. THAILAND SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 32. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 33. FRANCE SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 34. GERMANY SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 35. ITALY SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 36. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 37. QATAR SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 38. RUSSIA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 39. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 40. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 41. SPAIN SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 42. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 43. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 44. GLOBAL SPINE BIOLOGICS MARKET: SCORES
  • TABLE 45. GLOBAL SPINE BIOLOGICS MARKET: BUSINESS STRATEGY
  • TABLE 46. GLOBAL SPINE BIOLOGICS MARKET: PRODUCT SATISFACTION
  • TABLE 47. GLOBAL SPINE BIOLOGICS MARKET: RANKING
  • TABLE 48. GLOBAL SPINE BIOLOGICS MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 49. GLOBAL SPINE BIOLOGICS MARKET: MERGER & ACQUISITION
  • TABLE 50. GLOBAL SPINE BIOLOGICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 51. GLOBAL SPINE BIOLOGICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 52. GLOBAL SPINE BIOLOGICS MARKET: INVESTMENT & FUNDING
  • TABLE 53. GLOBAL SPINE BIOLOGICS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 54. GLOBAL SPINE BIOLOGICS MARKET: LICENSE & PRICING